Leading scientists and clinicians will convene in Boston for the 2026 Activated Egg Symposium, a one-day meeting focused on "Unique Human Egg Activation Pathways." The event, part of a series hosted by the Bedford Research Foundation since 2002, aims to foster scientific exchange and collaboration on one of the most fundamental questions in reproductive and developmental biology: how human eggs activate and initiate early embryonic development. The symposium will bring together experts from academia, fertility clinics, and biotechnology to discuss molecular and cellular mechanisms that shape egg activation, fertilization, and developmental competence.
The program will feature presentations on ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. By uniting voices across disciplines and sectors, the symposium seeks to encourage new partnerships and accelerate translational progress in fertility and developmental science.
"We still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine," said Ann A. Kiessling, Director of the Bedford Research Foundation.
The speaker lineup includes Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh; Ali H. Brivanlou of The Rockefeller University; Rafael Fissore of the University of Massachusetts Amherst; Ehsan Habibi of the Ottawa Hospital Research Institute and University of Ottawa; Jonathan van Blerkom of the University of Colorado, Boulder; Dietrich M. Egli of Columbia University Irving Medical Center; and Elizebeth Carr, America's first IVF baby, speaker and advocate. Their collective work spans ovarian biology, fertilization, egg activation, developmental competence, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The symposium's significance lies in its potential to bridge gaps between laboratory discovery and clinical application. Understanding egg activation is critical for improving fertility treatments, advancing assisted reproduction, and unlocking new avenues in stem cell science and developmental medicine. The focused one-day format is designed to maximize scientific exchange and audience engagement, providing a rare opportunity for researchers, clinicians, trainees, and innovators to interact directly with leaders in the field.
As reproductive technologies continue to evolve, the questions addressed at this symposium could inform future breakthroughs in regenerative medicine and embryo research. The event underscores the importance of cross-sector collaboration in addressing complex biological challenges and translating fundamental science into tangible health benefits.
